Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
---|
12/12/2007 | CN101087601A Compounds for inhibiting copper-containing amine oxidases and uses thereof |
12/05/2007 | EP1861356A1 Imines as ion channel modulators |
12/05/2007 | EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
11/28/2007 | CN100351228C Hydroxamic acid derivatives and the method for preparing thereof |
11/21/2007 | EP1856035A1 Process for preparaing protected amiidines |
11/21/2007 | CN100349860C Prepn. of fatty hydroxamate |
11/15/2007 | WO2007056469A3 Certain chemical entities, compositions, and methods |
11/15/2007 | US20070265323 Compounds for the treatment of metabolic disorders |
11/15/2007 | US20070265322 Compounds for the treatment of metabolic disorders |
11/14/2007 | EP1381355B1 Use of rhein and its derivatives as matrix metalloproteinase inhibitors |
11/08/2007 | US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand |
11/06/2007 | US7291728 Spirolactams and their synthesis |
11/06/2007 | US7291617 Arylamidine derivative or salt thereof |
11/01/2007 | WO2007077240A3 Functionalised nanoparticles, their production and use |
10/31/2007 | EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors |
10/31/2007 | EP1246795B1 Antibacterial agents |
10/30/2007 | US7288567 Inhibitors of histone deacetylase |
10/30/2007 | US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease |
10/25/2007 | US20070249719 Compounds for the treatment of metabolic disorders |
10/25/2007 | US20070249696 Compounds for the treatment of metabolic disorders |
10/24/2007 | CN100344616C Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders |
10/18/2007 | US20070244172 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244171 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244141 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof |
10/16/2007 | US7282522 Anti-aging skin care; e.g. N-[4-(N-hydroxycarbamoyl)phenyl]benzamide; inhibits collagenase and/or elastase expression; less skin irritation than conventional retinoic acid |
10/11/2007 | WO2007113644A2 New hdac inhibitors |
10/11/2007 | WO2007072179A3 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
10/11/2007 | WO2007005603A3 Novel hydroxamic acid-containing amino acid derivatives |
10/09/2007 | US7279601 Optically active α-aminooxyketone derivatives and process for production thereof |
10/09/2007 | US7279478 Cathepsin cysteine protease inhibitors |
10/03/2007 | CN100340545C Tetralone derivatives as antitumor agents |
10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
09/27/2007 | US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase |
09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
09/19/2007 | CN101039905A New histone deacetylases inhibitors |
09/18/2007 | USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
09/11/2007 | CA2254066C Compounds with anti-inflammatory and immunosuppressive activities |
09/05/2007 | CN101031541A 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
08/23/2007 | US20070197550 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
08/15/2007 | CN101018547A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
08/08/2007 | EP1814850A1 New histone deacetylases inhibitors |
08/01/2007 | CN101010298A Histone deacetylase inhibitor prodrugs |
07/26/2007 | US20070173542 Peptide deformylase inhibitors |
07/19/2007 | WO2007009083A3 Compounds with activity at retinoic acid receptors |
07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
07/12/2007 | WO2007008994A3 Glutamate aggrecanase inhibitors |
07/12/2007 | CA2636326A1 Functionalised nanoparticles, their production and use |
07/11/2007 | CN1997626A Inhibitors of histone deacetylase |
07/11/2007 | CN1997625A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
07/10/2007 | US7241921 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
07/10/2007 | CA2308850C Inhibitors of gap junction communication |
07/04/2007 | EP1581484B1 Hydroxamic acid derivatives having anti-inflammatory action |
07/03/2007 | US7238339 Chelate metal ions that can be detected either by their paramagnetic or radioactive properties; diagnostic and therapeutic agents |
06/28/2007 | WO2007072179A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
06/28/2007 | CA2633010A1 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
06/26/2007 | US7235689 Hydroxamic acid derivatives having anti-inflammatory action |
06/21/2007 | US20070142635 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
06/20/2007 | EP1796681A2 Compounds for inhibiting copper-containing amine oxidases and uses thereof |
06/19/2007 | US7232929 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
06/14/2007 | US20070135353 Crystalline n-formyl hydroxylamine compounds |
06/13/2007 | CN1980886A Alpha-amino acid derivatives with antiinflammatory activity |
06/12/2007 | CA2354023C Phenylglycine derivatives |
06/07/2007 | US20070129368 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
06/06/2007 | EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents |
06/06/2007 | EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
05/31/2007 | US20070123493 Benzamide derivative |
05/30/2007 | EP1789381A2 Inhibitors of histone deacetylase |
05/22/2007 | US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma |
05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
05/18/2007 | WO2006097279A8 Amidrazone compounds for combating animal pests |
05/10/2007 | WO2007051408A1 Compounds for preventing or treating the h.pylori infection, preparation methods and use therrof |
05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
05/10/2007 | US20070105905 Novel macrocycles for the treatment of cancer |
05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
05/09/2007 | EP1781714A1 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases |
05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
05/03/2007 | WO2006128121A3 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
04/26/2007 | US20070093675 reacting an oxalic acid diester and an N-alkyl-O-alkylhydroxylamine in the presence of a base; uses safe starting materials, requires no complicated operation |
04/25/2007 | CN1951912A Chiral alicyclic hydrocarbon hydroxamic acid derivative preparation method |
04/19/2007 | WO2007024869A3 Catalyst for making fluoroelastomer compositions and methods of using the same |
04/19/2007 | US20070088067 Novel amidine compounds for treating microbial infections |
04/18/2007 | CN1310904C Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
04/17/2007 | CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof |
04/11/2007 | EP1771167A2 Histone deacetylase inhibitors |
04/10/2007 | CA2336380C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
04/04/2007 | CN1939898A Chiral synthesis of combined protein deacetylated enzyme inhibitor |
03/22/2007 | WO2007031213A1 Dioxazine- and oxadiazine-substituted arylamides |
03/21/2007 | EP1763507A2 Alpha-amino acid derivates with antiinflammatory activity |
03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
03/21/2007 | CN1305839C Phenylglycine derivatives |
03/15/2007 | WO2007001211A3 Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the cytostatic efficiency and metastasis process inhibiting method |